John H. Tucker - Dec 3, 2021 Form 4 Insider Report for scPharmaceuticals Inc. (SCPH)

Role: President and CEO, Director
Signature: /s/ John H. Tucker
Stock symbol: SCPH
Transactions as of: Dec 3, 2021
Transactions value $: $39,553
Form type: 4
Date filed: 12/6/2021, 04:53 PM
Next filing: Feb 1, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SCPH	Common Stock	Purchase	$39.6K	+10K	+27.05%	$3.96	47K	Dec 3, 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $3.78 to $4.00, inclusive. The reporting person undertakes to provide to scPharmaceuticals Inc., any security holder of scPharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in footnote (1) to this Form 4

Content

The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $3.78 to $4.00, inclusive. The reporting person undertakes to provide to scPharmaceuticals Inc., any security holder of scPharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in footnote (1) to this Form 4